GlassScriptPhysician profile
Alexander Fontenot
NPI 1932589264
$9,949.55
in general payments reported to CMS, 2019-2025
36 companies · $2,497 in 2025
The $2,497 reported for 2025 was more than what 86% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2020: $214 · 2021: $618 · 2022: $1,919 · 2023: $2,598 · 2024: $1,183 · 2025: $2,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,517 · Consulting Fee: $1,500 · Travel and Lodging: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,517.42 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $1,261.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,912.53 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Elliquence, LLC | $1,500.00 | 2025 | Disc-Fx System |
| Genesys Orthopedics Systems, L.L.C. | $915.65 | 2022 | |
| Spinal Simplicity, LLC | $690.23 | 2023-2025 | Ha Minuteman G3-R |
| Mml US, INC. | $244.68 | 2022 | |
| Medtronic, INC. | $239.49 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Biotronik Nro, INC. | $177.56 | 2025 | Prospera |
| Saluda Medical Americas, INC. | $165.53 | 2024 | Evoke |
| Spr Therapeutics, INC | $129.65 | 2024-2025 | Sprint Pns System |
| Abbott Laboratories | $93.36 | 2019-2025 | Eterna |
| Neuronetics, INC. | $65.70 | 2022 | |
| Ucb, INC. | $61.60 | 2024-2025 | Bimzelx, Zilbrysq |
| Argenx US, INC. | $59.52 | 2024-2025 | Vyvgart Hytrulo |
| Vertos Medical, INC. | $59.45 | 2023-2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.28 | 2023 | Relistor |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $51.58 | 2025 | Leqembi, Vumerity, Tysabri |
| Scilex Pharmaceuticals INC. | $40.97 | 2023 | Ztlido |
| Virtus Pharmaceuticals LLC | $40.26 | 2023 | Levorphanol Tartrate |
| Horizon Therapeutics Plc | $38.63 | 2022-2023 | Krystexxa |
| Janssen Biotech, INC. | $38.62 | 2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $38.38 | 2025 | |
| Pfizer INC. | $37.55 | 2024-2025 | |
| Allergan, INC. | $36.97 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $36.14 | 2022 | |
| Forte Bio-Pharma LLC | $24.42 | 2021-2024 | Prolate, Nalocet |
| Lundbeck LLC | $22.27 | 2024 | Vyepti |
| Nalu Medical, INC. | $21.73 | 2024 | Nalu Neurostimulation System |
| Eisai INC. | $19.72 | 2025 | |
| Amneal Pharmaceuticals LLC | $19.02 | 2025 | Rytary |
| Medtronic USA, INC. | $18.92 | 2020 | |
| Redhill Biopharma INC. | $17.30 | 2020 | |
| Fidia Pharma USA INC. | $16.32 | 2022 | |
| Nevro Corp. | $15.92 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.79 | 2021 | |
| Painteq LLC | $14.94 | 2023 | Painteq |
| Alon Medical Technology | $14.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Fontenot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.